Cargando…
Using Targeted Virotherapy to Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back
Metastatic Ewing sarcoma (EWS) is often resistant to current multimodal chemotherapeutic regimens. Oncolytic virus therapy (OV) is a novel therapeutic platform whereby viruses can selectively infect as well as replicate in and kill tumor cells, while sparing normal tissues. The purpose of this study...
Autores principales: | Abdelbary, Hesham, Brown, Christopher W., Werier, Joel, Bell, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930196/ https://www.ncbi.nlm.nih.gov/pubmed/24672293 http://dx.doi.org/10.1155/2014/171439 |
Ejemplares similares
-
Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021) -
Bedside to bench and back to bedside: Translational implications of targeted intervertebral disc therapeutics
por: Rosenberg, Gary Joel, et al.
Publicado: (2017) -
Exploiting tumor epigenetics to improve oncolytic virotherapy
por: Forbes, Nicole E., et al.
Publicado: (2013) -
Bench-To-Bedside and Bedside Back to the Bench; Coordinating Clinical and Experimental Traumatic Brain Injury Studies
por: Agoston, Denes V., et al.
Publicado: (2012) -
Stress and tinnitus—from bedside to bench and back
por: Mazurek, Birgit, et al.
Publicado: (2012)